^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Capoxigem (apricoxib)

    i
    Associations
    News

    Trials

    Company:
    Adastra Pharma
    Drug class:
    COX2 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma (NCT05841550)
    Phase 1/2
    Oslo University Hospital
    Recruiting
    Last update posted :
    11/03/2023
    Initiation :
    05/19/2023
    Primary completion :
    05/19/2027
    Completion :
    05/19/2035
    KRAS • NRAS • IFNG • TNFA • RAS
    |
    KRAS mutation • NRAS mutation • RAS mutation
    |
    Capoxigem (apricoxib) • TG01 vaccine